Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe PubMed publications section text was updated to state that entries are auto-filled from PubMed and may not pertain to the study, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page no longer shows the government funding/NIH operating status notice; other study details and links remain unchanged.SummaryDifference0.3%

- Check34 days agoChange DetectedThe two screenshots show the Study Details page with no substantive changes to content or structure; only minor UI or rendering differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedMajor update: version bumped to v3.2.0 and a government funding/operating-status notice added; previous version v3.1.0 removed.SummaryDifference3%

- Check70 days agoChange DetectedAppended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.SummaryDifference0.4%

- Check84 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the Back to Top element. Overall, no substantive changes to core content or offerings.SummaryDifference0.2%

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.